Kirino and co-worker (73) have demonstrated that serum HO-1 levels are increased in patients with atopic dermatitis (AD) and that the levels correlate with the severity of clinical manifestations and conventional disease markers. The gene discussed is HMOX1; the disease is Alzheimer disease.